A key element of the U.S. Food and Drug Administration's mission is focused on helping to ensure that all products we regulate, including drugs available to consumers...

Bayer has exercised its option, under a change-in-control clause in the collaboration agreement with Loxo Oncology, to obtain the exclusive licensing rights for the g...

A new reversible, drug-free antiplatelet therapy could reduce the risk of blood clots and potentially prevent cancer metastasis, according to a study published today ...

-          TOTAL AVAILABLE FUNDS ON 31 DECEMBER 2018: €15.2M -          FOUR ONGOING CLINICAL TRIALS ON THREE DRUG CANDIDATES -          UPDATE ON NEW ACTIVE AGENT SC...

New courier zones announced in the UK LEUVEN, BELGIUM (February 14, 2019) – As an advocate for researchers in the genomics age, Integrated DNA Technologies (IDT) is ...

The possibility of using hematopoietic stem cells to restore production of normal hemoglobin is being investigated as a potential strategy to reduce the number of blo...

Researchers have made a new discovery about cancer cell metastasis that could completely change treatment approaches in the battle against cancer. Professor Michae...

Sangamo Therapeutics has posted lackluster data from a phase 1/2 trial of genome-editing therapy SB-913. The treatment failed to have the hoped-for effects on patient...

A simple drug cocktail that converts cells neighboring damaged neurons into functional new neurons could potentially be used to treat stroke, Alzheimer's disease, and...

New research on how cancer mutations influence a certain type of receptor on the cell membrane opens the way for the development of tailored drugs for certain cancers...